Toronto Dominion Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Toronto Dominion Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,700	Closed	-$2.65M	–	2439
2025 Q4	$2.65M	Sell	21,700 -104,300	-83%	-$12M	﹤0.01%	1029
2025 Q3	$12.6M	Buy	126,000 +103,300	+455%	+$9.3M	0.02%	547
2025 Q2	$1.88M	Buy	+22,700	New	+$1.81M	﹤0.01%	994

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Toronto Dominion Bank's XBI Position: Q1 2026 in Review

Toronto Dominion Bank reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 100% in Q1 2026, selling an estimated $1.24M and leaving 17 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

Toronto Dominion Bank first reported a position in XBI in Q2 2013 and has held it in 50 quarters since. The position peaked at $864M in Q2 2021. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Toronto Dominion Bank held 17 shares of State Street SPDR S&P Biotech ETF worth $2.12K as of Q1 2026.
Toronto Dominion Bank sold 9,914 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $1.24M.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #2004 holding.
Toronto Dominion Bank first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 50 quarters since.
Toronto Dominion Bank's State Street SPDR S&P Biotech ETF position peaked at $864M in Q2 2021.
815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.